Research output per year
Research output per year
Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/01/20 → 31/12/24 |
Funding
- National Health and Medical Research Council (NHMRC) (Australia): A$735,224.00
Keywords
- antibiotic resistance
- mathematical modelling
- Pseudomonas aeruginosa
- mutation
- genomics
-
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity
Agyeman, A. A., López-Causapé, C., Rogers, K. E., Lucas, D. D., Cortés-Lara, S., Gomis-Font, M. A., Fraile-Ribot, P., Figuerola, J., Lang, Y., Franklyn, E. R. T., Lee, W. L., Zhou, J., Zhang, Y., Bulitta, J. B., Boyce, J. D., Nation, R. L., Oliver, A. & Landersdorfer, C. B., Sept 2023, In: International Journal of Antimicrobial Agents. 62, 3, 10 p., 106887.Research output: Contribution to journal › Article › Research › peer-review
4 Citations (Scopus) -
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance
Tait, J. R., Harper, M., Cortés-Lara, S., Rogers, K. E., López-Causapé, C., Smallman, T. R., Lang, Y., Lee, W. L., Zhou, J., Bulitta, J. B., Nation, R. L., Boyce, J. D., Oliver, A. & Landersdorfer, C. B., Aug 2023, In: Antimicrobial Agents and Chemotherapy. 67, 8, 12 p., e0041423.Research output: Contribution to journal › Article › Research › peer-review
3 Citations (Scopus) -
Clinical pharmacological considerations in an early intravenous to oral antibiotic switch: are barriers real or simply perceived?
Landersdorfer, C. B., Gwee, A. & Nation, R. L., Sept 2023, In: Clinical Microbiology and Infection. 29, 9, p. 1120-1125 6 p.Research output: Contribution to journal › Review Article › Research › peer-review
8 Citations (Scopus)